Vaccinogen, Inc. is a internationally structured biotechnology company focused on the development and commercialization of vaccines and immunotherapeutic products for the battle of cancer. Vaccinogen, Inc. a Maryland corporation, represents our global headquarters and is located at Fell Street, Baltimore, MD . We also maintain offices, laboratory and scientific manufacturing space at Marco Polostraat . VM, Emmen, the Netherlands. Currently, Vaccinogen Ireland R amp D Company Ltd, is in the process of establishing a permanent research facility in Dublin. Our mission is to capitalize on several decades of basic and clinical research, harnessing the inborn strength of the immune system. Vaccinogen understands the heterogeneity of tumors and acknowledges the need to address each unique and individual tumor through manufacturing of autologous, personalized cancer vaccines, for the benefit to of patients, the society and health care providers.
Quote | Vaccinogen Inc (OTCMKTS:VGEN)
Last: | $ |
---|---|
Change Percent: | 0.00% |
Open: | $N/A |
Close: | $0.0001 |
High: | $N/A |
Low: | $N/A |
Volume: | 0 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Vaccinogen Inc (OTCMKTS:VGEN)
Message Board Posts | Vaccinogen Inc (OTCMKTS:VGEN)
Subject | By | Source | When |
---|---|---|---|
VGEN registration revoked: | Renee | investorshub | 04/26/2019 1:40:21 PM |
As warned, $VGEN SEC Suspension for delinquent Financials/Filings: | Renee | investorshub | 09/26/2017 1:48:50 PM |
VGEN is severely delinquent in filing the company's | Renee | investorshub | 09/19/2017 10:46:07 PM |
After doing some research, I can say you | dealhunter65 | investorshub | 03/23/2017 5:26:42 PM |
I looked into this a few months ago. | Hanibal | investorshub | 03/09/2017 1:50:38 AM |
News, Short Squeeze, Breakout and More Instantly...